Intravenous administration of the selective toll-like receptor 7 agonist DSR-29133 leads to anti-tumor efficacy in murine solid tumor models which can be potentiated by combination with fractionated radiotherapy
| Image |  |
|---|---|
| Description | scientific article published on 5 March 2016 |
| Author/s |
author: Tim M. Illidge Amy L. Adlard Ian Stratford |
| Publication date | March 5, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |